Market Overview

Standpoint Research Downgrades Hi-Tech Pharmacal Co., Inc. to Hold

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for HITK

DateFirmActionFromTo
Aug 2013CRT CapitalDowngradesBuyFairly Valued
Aug 2013Standpoint ResearchDowngradesBuyHold
Mar 2013Standpoint ResearchUpgradesHoldBuy

View More Analyst Ratings for HITK
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (HITK)

Around the Web, We're Loving...

Get Benzinga's Newsletters